Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-The-Counter Human Use; Final Rule for Professional Labeling of Aspirin, Buffered Aspirin, and Aspirin in Combination With Antacid Drug Products; Correction
other · Food and Drug Administration · Rule · Published 1998-12-01 · Effective 1999-10-25 · 63 FR 66015
Document
Document number
98-31854
Federal Register citation
63 FR 66015
CFR reference
21 CFR 343
Type
Rule
Action
Final rule; correction.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-12-01
Effective date
1999-10-25
HHS docket
Docket No. 77N-094A
Abstract
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of October 23, 1998 (63 FR 56802). The document provided for professional labeling for over-the- counter (OTC) internal analgesic, antipyretic, and antirheumatic drug products containing aspirin, buffered aspirin, and aspirin in combination with an antacid. The document published with some inadvertent editorial errors. This document corrects those errors.